Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

Overview | Financials
Company Name Arcturus Therapeutics Holdings Inc.
Symbol ARCT
Currency USD
Price 18
Market Cap 486,759,600
Dividend Yield 0%
52-week-range 17.52 - 45
Industry Biotechnology
Sector Healthcare
CEO Mr. Joseph E. Payne M.Sc.
Website https://arcturusrx.com

An error occurred while fetching data.

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations

Related Stocks

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.297 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

4.4 USD

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

2.61 USD

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

0.903 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

3.46 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

43.82 USD

Immatics N.V. logo

Immatics N.V.

IMTX

9.33 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.282 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

9.71 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

29.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD